Article
Company News Release
OpenClinica, LLC, announces the availability of the latest version of its popular open source clinical trials software. The OpenClinica v3.1.3 release contains over 100 fixes and enhancements, including:
These, and many other, advancements are the result of efforts by OpenClinica, LLC and members of the OpenClinica community. “OpenClinica community contributors have helped fuel a lot of the progress reflected in this release,” said Cal Collins, OpenClinica’s CEO. “This release is evidence that a strong open source community can drive the software to a higher quality standard.”
OpenClinica 3.1.3 Community Edition is freely available for download on the OpenClinica community website.
The company also announces that version 3.1.3 of its commercially backed OpenClinica Enterprise Edition is also now available. OpenClinica Enterprise is provided as fully validated, enhanced, and supported implementation of the open source technology, ideal for mission critical environments. This latest rendition of the OpenClinica Enterprise Edition also leverages Akamai’s global content delivery network (CDN), further accelerating the application’s performance.
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.